T1	Participants 58 82	intrahepatic cholestasis
T2	Participants 195 237	intrahepatic cholestasis in pregnant women
T3	Participants 402 449	cholestatic patients with chronic liver disease
T4	Participants 464 676	220 inpatients (26% chronic active hepatitis, 68% cirrhosis, 6% primary biliary cirrhosis) with stable (1 month or more) at least twofold increases in serum total and conjugated bilirubin and alkaline phosphatase
T5	Participants 1610 1618	syndrome
